REG - Maven Inc&Grwth 5 - Directorate Change

Maven Income and Growth VCT 5Announcement

17/12/2024 15:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241217:nRSQ4594Qa&default-theme=true

RNS Number : 4594Q  Maven Income and Growth VCT 5 PLC  17 December 2024

 

 

 

 

Maven Income and Growth VCT 5 PLC

 

Directorate Change

 

Appointment of Director

The Board of Maven Income and Growth VCT 5 PLC ("the Company") is pleased to
announce the appointment of Brian Phillips as an independent Non-executive
Director, with effect from 1 January 2025.

 

Brian is a member of the Institute of Chartered Accountants of Scotland and
has over 35 years' Board level experience across industry, private equity
investment and corporate finance. He is a member of the Advisory Boards of
Harwood Private Equity III, IV, V and VI and is a partner in Imbiba, a small
UK private equity business in the hospitality sector.

 

He is currently a non-executive director of AIM-quoted Tissue Regenix Group
Plc, a healthcare business providing wound care products, and NAHL Group Plc,
a provider of services to catastrophic injury sufferers, together with legal
services. He is also a director of Motocaddy Limited, a distributor of golf
products; Purple Dragon (Holdings) Limited, a high end family club operator;
and Pet Mate Limited, a distributor of pet products and accessories.

 

Brian will also serve on the Company's Audit, Management Engagement,
Nomination, Remuneration and Risk Committees, and will stand for election by
Shareholders at the Annual General Meeting (AGM), currently scheduled to be
held on 29 April 2025.

 

As at the date of this announcement, he has no current beneficial interest in
the Company's Ordinary Shares and, in relation to his appointment, there is no
additional information required to be disclosed pursuant to Listing Rule
9.6.13 R.

 

Retirement of Director

As required by Listing Rule 9.6.11, the Company also advises that Gordon
Humphries, who has served as an independent Non-executive Director since 7
February 2006 and as Chair of the Audit and Risk Committees, has decided to
retire at the conclusion of the 2025 AGM and will not stand for re-election.

 

The Board would like to thank Gordon for his many years of dedication and
commitment to the Company in his role as Non-executive Director and as Chair
of the Audit and Risk Committees, including overseeing the appointment of
Maven Capital Partners UK LLP as Manager and the Company adopting a new
investment policy, allowing its transition from an AIM focussed VCT to a
hybrid private equity and AIM investment vehicle. The Board wishes Gordon
every success for the future.

 

Following Gordon's retirement, Brian Phillips will assume the role of Chair of
the Audit and Risk Committees.

 

 

 

Maven Capital Partners UK LLP

Company Secretary

 

17 December 2024

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEDLFFZLLLFBE